Hana Pharm Co Ltd Strategic Asset Allocation Index
Hana Pharm Co Ltd strategic asset allocation index. Hana Pharm Co Ltd (293480) has a Strategic Asset Allocation Index of 58.9% as of December 2017. Strategic assets (PP&E of ₩46.65 Billion plus long-term investments of ₩1.23 Billion) total ₩47.89 Billion, measured against net assets of ₩81.30 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 293480 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Hana Pharm Co Ltd (2016–2017)
Strategic asset allocation index of Hana Pharm Co Ltd from 2016 to 2017. This chart shows how Hana Pharm Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of December 2017, the index stands at 58.9%, representing strategic assets of ₩47.89 Billion against net assets of ₩81.30 Billion KRW. Check how tangible is Hana Pharm Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Hana Pharm Co Ltd Strategic Asset Allocation Index by Year (2016–2017)
Hana Pharm Co Ltd strategic asset allocation index by year from 2016 to 2017. The table below presents the year-by-year Strategic Asset Allocation Index for Hana Pharm Co Ltd from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hana Pharm Co Ltd (293480) market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 58.9% | ₩47.89 Billion | ₩46.65 Billion | ₩1.23 Billion | ₩81.30 Billion | ▼ -32.7 pp |
| 2016 | 91.6% | ₩50.82 Billion | ₩49.66 Billion | ₩1.15 Billion | ₩55.48 Billion | — |